Advancing excellence in laboratory medicine for better healthcare worldwide

GC 2022 Presentations

FRIDAY – 28th October 2022

 

Welcome Address by the European Commission

European Commission, DG Health and Food Safety
Unit C2 – State of Health, European Semester, Health Technology Assessment, Brussels

 

 

SATURDAY – 29th October 2022

 

Special Day Celebrating the Rich History of the IFCC Organization

Welcome and Opening of the General Conference 

Co-Chairs: Khosrow Adeli & David Kinniburgh

IFCC: Emerging Stronger Post-Pandemic

 

SESSION 1

IFCC PAST PRESIDENTS SYMPOSIUM:

70 Years of Global Leadership in Laboratory Medicine
IFCC: A Glorious History of Global Cooperation & Major Scientific/Educational Advances

Moderator: Prof. Khosrow Adeli

SESSION 2

IFCC REGIONAL FEDERATION PRESIDENTS SYMPOSIUM:

History and Major Achievements of Regional Federations Around the World

Moderator: Dr. Alexander Haliassos

 

SESSION 3
IFCC 70TH ANNIVERSARY SYMPOSIUM
Central Role of Lab Medicine in Patient Care & Public Health – A Look into the Future

Moderator: Dr. David Kinniburgh

  • Khosrow Shotorbani (Lab 2.0) CEO, Project Santa Fe Foundation/Founder, Lab 2.0 Strategic Services

Role of the clinical laboratory in future era of healthcare as we transition from volume to value

 

  • Dr. David Grenache (AACC) Chief Scientific Officer, TriCore Reference Laboratories
    Laboratory Director/Clinical Professor of Pathology, University of New Mexico

How we harnessed laboratory data to improve health and economic outcomes

 

  • Dr. Francis Moussy (WHO) Lead, Secretariat of the WHO Model List of Essential IVD (the EDL) World Health Organization, WHO – Geneva, Switzerland

The WHO Model List of Essential In Vitro Diagnostics

 

  • Prof Christa Cobbaert (IVDR) Vice-Chair, IFCC Scientific Division; Clinical Chemistry & Laboratory Medicine, Leiden University Medical Center; Leiden, the Netherlands

Critical implications of the IVDR roll out for Continuation and Innovation in Diagnostics

 

SESSION 4
INDUSTRY FORUM: THE FUTURE OF IVD OVER THE NEXT DECADE

Moderators: Tricia Ravalico (Abbott) and Joseph Passarelli (Roche)

  • Anne Skurup Senior Medical Advisor, Radiometer Medical; Denmark

Meeting the demand for clinical studies for regulatory approval: how can IFCC and the IVD industry collaborate to meet the need?

 

  • Dr. Frank Vitzthum Siemens Healthcare Diagnostics Products GmbH, Managing Director; Germany

Emerging trends

 

  • Els Melis  EMA Senior Marketing Manager, QuidelOrtho, Belgium

What have we learned from the experience of COVID

 

  • Brendan Meyer Associate Director, Medical Affairs EMEA, Integrated Diagnostic Solutions, Becton Dickinson Life Sciences; United Kingdom

IVD industry partnership with IFCC

 

 

SUNDAY – 30th October 2022

 SESSION 1
IFCC Functional Groups - Reports & Future Plans/Vision

IFCC EXECUTIVE BOARD PRESENTATIONS – OVERVIEW
Co-Chairs: Khosrow Adeli & David Kinniburgh

Finance Report

Corporate Members Report

 

SCIENTIFIC DIVISION (SD)

 

SESSION 2

EDUCATION & MANAGEMENT DIVISION (EMD)

EMERGING TECHNOLOGY DIVISION (ETD)

 

SESSION 3
COMMUNICATIONS & PUBLICATIONS DIVISION (CPD)

CONFERENCES & CONGRESSES COMMITTEE (C-CC)

NEW IFCC TASK FORCES/PROJECTS

TF Global Newborn Screening (TF-NBS)

TF Global Lab Quality (TF-GLQ )

 

SESSION 4
NEW IFCC TASK FORCES/PROJECTS

TF Global Reference Interval Database (TF-GRID)

TF Outcome Studies in Lab Med (TF-OSLM)

TF Global eLearning/eAcademy (TF-GEL)

 

SUMMARY REMARKS

Outcomes of the GC & new directions for the IFCC

 
Website developed by Insoft